An outstanding Q2 given the conditions. CLSE’s focus on speciality products has resulted in a significant expansion of margins. This year 2015-16, they will end up with an eps of around Rs.45.
I think next year will witness an increase in their topline as well. I think volumes have already started picking up, but given the lower basmati prices, this really doesn’t reflect in their topline. Additionally, they are setting a target of Rs.100 crore in the Indian markets alone and plan to reach there next year.
All in all, a good buy even at current levels.
| Subscribe To Our Free Newsletter |
